Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tight glycemic control? Negative.

P Raskin1

  • 1University of Texas Southwestern Medical Center, Dallas.

Hospital Practice (Office Ed.)
|February 1, 1992
PubMed
Summary
This summary is machine-generated.

Strict blood glucose control may not prevent diabetic complications like retinopathy and nephropathy, and can even be dangerous for some patients. Achieving normal blood glucose levels is often impossible and poses risks.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The effect of basal-bolus therapy varies with baseline 1,5-anhydroglucitol level in people with Type 2 diabetes: a post hoc analysis.

Diabetic medicine : a journal of the British Diabetic Association·2018
Same author

Effect of adding insulin degludec to treatment in patients with type 2 diabetes inadequately controlled with metformin and liraglutide: a double-blind randomized controlled trial (BEGIN: ADD TO GLP-1 Study).

Diabetes, obesity & metabolism·2016
Same author

AMG 151 (ARRY-403), a novel glucokinase activator, decreases fasting and postprandial glycaemia in patients with type 2 diabetes.

Diabetes, obesity & metabolism·2015
Same author

Pulmonary function over 2 years in diabetic patients treated with prandial inhaled Technosphere Insulin or usual antidiabetes treatment: a randomized trial.

Diabetes, obesity & metabolism·2011
Same author

Glycaemic control with liraglutide: the phase 3 trial programme.

International journal of clinical practice. Supplement·2010
Same author

Twice-daily and three-times-daily dosing of a repaglinide/metformin fixed-dose combination tablet provide similar glycaemic control.

Diabetes, obesity & metabolism·2009
Same journal

Oral contraceptives: an update.

Hospital practice (Office ed.)·1995
Same journal

Progress in the immunogenetics of rheumatoid arthritis.

Hospital practice (Office ed.)·1995
Same journal

An asymptomatic lung nodule in an elderly woman with joint pain.

Hospital practice (Office ed.)·1995
Same journal

Defusing status epilepticus.

Hospital practice (Office ed.)·1995
Same journal

Persistent fever and flank discomfort in a young woman.

Hospital practice (Office ed.)·1995
Same journal

New thoughts on attention-deficit/hyperactivity disorder.

Hospital practice (Office ed.)·1995
See all related articles

Area of Science:

  • Endocrinology
  • Diabetology
  • Ophthalmology
  • Nephrology

Background:

  • Diabetic complications, including proliferative retinopathy and nephropathy, are a major concern in diabetes management.
  • The relationship between glycemic control and the development of these microvascular complications is complex and not fully understood.
  • Current guidelines often emphasize tight glycemic control to prevent or delay diabetic complications.

Framework:

  • This study examines the paradoxical observation that some poorly controlled diabetic patients do not develop severe complications, while some tightly controlled patients do.
  • It questions the universal applicability and safety of achieving normalized blood glucose levels in all patients.
  • The research explores the potential for iatrogenic harm from aggressive glucose-lowering strategies.

Related Experiment Videos

Implementation:

  • The study reviews existing clinical data and patient outcomes.
  • It analyzes factors that may influence the development of retinopathy and nephropathy independent of glycemic control.
  • The research considers the feasibility and risks associated with intensive glycemic normalization.

Implications:

  • Findings suggest that a one-size-fits-all approach to glycemic control in diabetes may be inappropriate.
  • It highlights the need for individualized treatment strategies that balance the benefits and risks of glucose normalization.
  • The study underscores the importance of monitoring for complications even in patients with seemingly good glycemic control and considering alternative risk factors.